- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/106 - VibrioCampylobacter
Patent holdings for IPC class A61K 39/106
Total number of patents in this class: 118
10-year publication summary
|
10
|
5
|
3
|
8
|
5
|
1
|
2
|
5
|
1
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Intervet International B.V. | 1282 |
7 |
| The United States of America as represented by the Secretary of the Navy | 2744 |
5 |
| The Governors of the University of Alberta | 868 |
5 |
| The Brigham and Women's Hospital, Inc. | 2181 |
4 |
| MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. | 23 |
4 |
| Elanco Tiergesundheit AG | 415 |
4 |
| The Regents of the University of California | 19887 |
3 |
| Lee, Shee Eun | 5 |
3 |
| Rhee, Joon Haeng | 5 |
3 |
| Sumitomo Chemical Company, Limited | 9046 |
2 |
| Idemitsu Kosan Co., Ltd. | 4214 |
2 |
| The General Hospital Corporation | 4724 |
2 |
| Eidgenossische Technische Hochschule Zurich | 99 |
2 |
| Jiangnan University | 1525 |
2 |
| The Kitasato Institute | 151 |
2 |
| Ostrich Pharma KK | 16 |
2 |
| UEA Enterprises Limited | 62 |
2 |
| University of Louisville Research Foundation, Inc. | 720 |
2 |
| Valneva Sweden AB | 9 |
2 |
| Quadram Institute Bioscience | 42 |
2 |
| Other owners | 58 |